Minetta Liu

Minetta Liu at Mayo Clinic is a leader in translational liquid biopsy research and was a key investigator in the PATHFINDER studies validating the Galleri multi-cancer early detection test in real-world clinical populations. Her work bridges bench-to-bedside translation of cfDNA methylation-based diagnostics and she has contributed to multiple prospective cohort studies of MCED performance.